Venous blood |
Sodium, plasma (mmol/L) |
142 |
137– 44 mmol/L |
Potassium, plasma (mmol/L) |
4.4 |
3.5–4.5 mmol/L |
Chloride, plasma (mmol/L) |
107 |
98–107 mmol/L |
Bicarbonate, plasma (mmol/L) |
5.8 (L) |
23–27 mmol/L |
Anion gap* (mmol/L) |
29 (H) |
8–12 mmol/L |
Albumin, plasma (g/L) |
25 (L) |
35–52 mmol/L |
Total bilirubin, plasma (μmol/L) |
5 |
<19 μmol/L |
ALP, plasma (U/L) |
251 (H) |
43–105 U/L |
ALT, plasma (U/L) |
11 |
<53 U/L |
Urea, plasma (mmol/L) |
4.9 |
3.1–7.8 mmol/L |
Creatinine, plasma (μmol/L) |
176 (H) |
65–109 μmol/L |
eGFR (CKD-EPI) (ml/min/1.73m2) |
32 |
>90 ml/min/1.73m2 |
Lactate, plasma (mmol/L) |
2.4 (H) |
<2.2 mmol/L |
Beta-hydroxybutyrate, plasma (mmol/L) |
2.92 (H) |
≤0.30 mmol/L |
Osmolality, serum (mOsm/kg) |
294 |
274–295 mOsm/kg |
Osmolal gap, plasma** (mOsm/kg) |
3 |
<10 mOsm/kg |
Random glucose, plasma (mmol/L) |
8.3 |
- |
Acetaminophen, serum (μmol/L) |
119 |
Therapeutic range: 66–199 μmol/L |
Arterial blood |
pH |
7.17 (L) |
7.35–7.45 |
PaCO2 (kPa) |
1.73 |
4.66–6.00 kPa |
PaO2 (kPa) |
12.4 |
10–13.33 kPa |
Actual bicarbonate (mmol/L) |
4.7 (L) |
22–26 mmol/L |
Base excess (mmol/L) |
−21.7 (L) |
–2.0–+2.0 mmol/L |
Spot urine |
Sodium, urine (mmol/L) |
93 |
- |
Potassium, urine (mmol/L) |
26 |
- |
Chloride, urine (mmol/L) |
<20 |
- |
Urine anion gap*** (mmol/L) |
>99 (H) |
<10 mmol/L |
Urine organic acids analysis by LC-MS/MS. |
Significant hyper-excretion of pyroglutamic acid. |
|